Clinical Characteristics of Coronavirus Disease 2019 in China.

PubWeight™: 9.53‹?› | Rank: Top 0.1%

🔗 View Article (PMID 32109013)

Published in N Engl J Med on February 28, 2020

Authors

Wei-Jie Guan1, Zheng-Yi Ni1, Yu Hu1, Wen-Hua Liang1, Chun-Quan Ou1, Jian-Xing He1, Lei Liu1, Hong Shan1, Chun-Liang Lei1, David S C Hui1, Bin Du1, Lan-Juan Li1, Guang Zeng1, Kwok-Yung Yuen1, Ru-Chong Chen1, Chun-Li Tang1, Tao Wang1, Ping-Yan Chen1, Jie Xiang1, Shi-Yue Li1, Jin-Lin Wang1, Zi-Jing Liang1, Yi-Xiang Peng1, Li Wei1, Yong Liu1, Ya-Hua Hu1, Peng Peng1, Jian-Ming Wang1, Ji-Yang Liu1, Zhong Chen1, Gang Li1, Zhi-Jian Zheng1, Shao-Qin Qiu1, Jie Luo1, Chang-Jiang Ye1, Shao-Yong Zhu1, Nan-Shan Zhong1, China Medical Treatment Expert Group for Covid-19

Author Affiliations

1: From the State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University (W.G., W.L., J.H., R.C., C.T., T.W., S.L., Jin-lin Wang, N.Z., J.H., W.L.), the Departments of Thoracic Oncology (W.L.), Thoracic Surgery and Oncology (J.H.), and Emergency Medicine (Z.L.), First Affiliated Hospital of Guangzhou Medical University, and Guangzhou Eighth People's Hospital, Guangzhou Medical University (C.L.), and the State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University (C.O., P.C.), Guangzhou, Wuhan Jinyintan Hospital (Z.N., J.X.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Yu Hu), the Central Hospital of Wuhan (Y.P.), Wuhan No. 1 Hospital, Wuhan Hospital of Traditional Chinese and Western Medicine (L.W.), Wuhan Pulmonary Hospital (P.P.), Tianyou Hospital Affiliated to Wuhan University of Science and Technology (Jian-ming Wang), and the People's Hospital of Huangpi District (S.Z.), Wuhan, Shenzhen Third People's Hospital and the Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases (L. Liu), and the Department of Clinical Microbiology and Infection Control, University of Hong Kong-Shenzhen Hospital (K.-Y.Y.), Shenzhen, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai (H.S.), the Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin (D.S.C.H.), and the Department of Microbiology and the Carol Yu Center for Infection, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pok Fu Lam (K.-Y.Y.), Hong Kong, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (B.D.), and the Chinese Center for Disease Control and Prevention (G.Z.), Beijing, the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (L. Li), Chengdu Public Health Clinical Medical Center, Chengdu (Y.L.), Huangshi Central Hospital of Edong Healthcare Group, Affiliated Hospital of Hubei Polytechnic University, Huangshi (Ya-hua Hu), the First Hospital of Changsha, Changsha (J. Liu), the Third People's Hospital of Hainan Province, Sanya (Z.C.), Huanggang Central Hospital, Huanggang (G.L.), Wenling First People's Hospital, Wenling (Z.Z.), the Third People's Hospital of Yichang, Yichang (S.Q.), Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan (J. Luo), and Xiantao First People's Hospital, Xiantao (C.Y.) - all in China.

Associated clinical trials:

Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19 | NCT04316728

COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study | NCT04329559

Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study (Covid-VAS) | NCT04333693

Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 (REPLACECOVID) | NCT04338009

Pyridostigmine in Severe SARS-CoV-2 Infection (PISCO) | NCT04343963

Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation (UPSAT) | NCT04344561

COVID19-hematological Malignancies: the Italian Hematology Alliance | NCT04352556

Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease | NCT04352803

Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives | NCT04357535

Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19) | NCT04358029

Liver Injury in Patients With COVID-19 | NCT04358380

Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia (COP-COVID-19) | NCT04358783

Covid-19 Associated Coagulopathy | NCT04360824

Pilot Study on Cytokine Filtration in COVID-19 ARDS (CytokCOVID19) | NCT04361526

Passive Immunity Trial of Nashville II for COVID-19 (PassItOnII) | NCT04362176

COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador | NCT04362969

Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections (REMDECO-19) | NCT04365725

C5a Receptor Expression - COVID-19 (C5-COV) (C5-COV) | NCT04369820

Predicting Death and ICU Admission in COVID-19 Patients in ED | NCT04371562

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 (TREATNOW) | NCT04372628

Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs (ACICOVID) | NCT04373759

Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19 | NCT04377503

Analysis of Mortality of Critically Ill Patients With COVID-19 | NCT04379258

Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 (CLUSCO) | NCT04379544

Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome | NCT04380935

COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada | NCT04397328

Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients (COVELEC) | NCT04414059

Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms (COVID-EP) | NCT04420312

Use of Remote Monitoring for COVID-19 Patient (RPM) | NCT04425720

Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants (CORhum) | NCT04426279

Predictive Factors COVID-19 Patients (MI-COVID) | NCT04427345

Evaluating Clinical Parameters of COVID-19 in Pregnancy (COpregVID) | NCT04470583

WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey (WHF) | NCT04475471

Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial (DART) | NCT04482621

SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study | NCT04494776

The McGill RAAS-COVID-19 Randomized Controlled Trial (RAAS-COVID) | NCT04508985

Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19 (PENFS COVID-19) | NCT04514627

Fenofibrate Intervention as COVID-19 Therapy (FERMIN) | NCT04517396

Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-based Study Platform | NCT04525118